Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$4.88M Sell
203,440
-59,633
-23% -$1.48M 0.05% 348
2014
Q4
$6.96M Buy
263,073
+192,346
+272% +$4.94M 0.07% 272
2014
Q3
$1.72M Buy
70,727
+2,790
+4% +$65.3K 0.02% 498
2014
Q2
$1.77M Sell
67,937
-1,563
-2% -$39.9K 0.02% 513
2014
Q1
$1.66M Buy
69,500
+2,318
+3% +$48.8K 0.02% 507
2013
Q4
$1.31M Buy
67,182
+2,897
+5% +$58.3K 0.02% 539
2013
Q3
$1.36M Sell
64,285
-26,888
-29% -$588K 0.03% 508
2013
Q2
$2.01M Buy
+91,173
New +$2.21M 0.04% 415

Other funds holding EXC

Baird's EXC Position: Q1 2015 in Review

Baird reduced its Exelon (EXC) stake by 23% in Q1 2015, selling an estimated $1.48M and leaving 203,440 shares worth $4.88M. The position accounts for 0.05% of the portfolio, ranked #348.

Baird first reported a position in EXC in Q2 2013 and has held it in 8 quarters since. The position peaked at $6.96M in Q4 2014. 731 funds tracked by Wall St. Rank hold EXC as of Q1 2015.

  • Baird held 203,440 shares of Exelon worth $4.88M as of Q1 2015.
  • Baird sold 59,633 Exelon shares in Q1 2015, an estimated $1.48M.
  • Exelon made up 0.05% of Baird's portfolio in Q1 2015, its #348 holding.
  • Baird first reported a position in Exelon in Q2 2013 and has held it in 8 quarters since.
  • Baird's Exelon position peaked at $6.96M in Q4 2014.
  • 731 funds tracked by Wall St. Rank held Exelon as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.